Rani Therapeutics Holdings, Inc.
- RANI
- NASDAQ
- Biotechnology
- Oral Biologic Delivery (RaniPill)
- Clinical-Stage Biopharma
$0.64
Today +0.33%Quote Oct 19, 2026, 02:33 PM UTC
−24.78%over the last month
Max drawdown −25.7%From 1-month high −25.7%3 months −6.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$120.3M
Approximate share count
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$15.67
+2338.2% from here
Floor
$0.58
9.2% below price
Where the price sits
7 analysts
Analyst range, low to high
$9.00$28.00
- Price $0.64
- Resistance $0.70
- Consensus $15.67
Analysts' average target sits about 2338% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about RANIPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
70